BMCS 3rd Conformational Design in Drug Discovery 2026
WuXi AppTec is pleased to participate in the BMCS 3rd Conformational Design in Drug Discovery 2026 conference, taking place March 2, in London, United Kingdom. Organized by the Royal Society of Chemistry Biological & Medicinal Chemistry Sector (BMCS), this event brings together medicinal chemists, structural biologists, and drug discovery experts to explore how conformational design principles can be harnessed to improve drug efficacy, selectivity, and developability.
At BMCS Conformational Design in Drug Discovery 2026, the program will cover topics including strategies for controlling molecular conformation, case studies demonstrating successful applications in lead optimization, integration of structural insights into medicinal chemistry workflows, and emerging tools that enhance rational design. The meeting provides a focused forum for scientific exchange and practical discussion on the impact of conformation on pharmacological performance and translational success.
At WuXi AppTec, we support medicinal and discovery chemistry efforts with a comprehensive suite of services that help advance small molecule programs from early concept to candidate selection. Our capabilities include design and synthesis, structural analysis support, analytical and profiling assays, in vitro and in vivo pharmacology, and DMPK integration — enabling partners to refine compounds with greater precision and confidence.
We look forward to connecting in London and exploring how our chemistry platforms can support your discovery goals in conformational design and beyond.
To schedule a dedicated meeting with our team, please fill out the form on the right.
Resource Links
Research Chemistry Services
Resource Type: Brochure
WuXi AppTec Biology Services
Resource Type: Brochure
